Common Symptoms of Tigecycline-Induced Liver Damage
Tigecycline, an antibiotic used for serious infections, can cause liver damage (hepatotoxicity) in some patients. Symptoms often appear within days to weeks of starting treatment and include:
- Nausea and vomiting
- Abdominal pain, especially in the upper right quadrant
- Fatigue and weakness
- Jaundice (yellowing of skin or eyes)
- Dark urine
- Pale or clay-colored stools
These align with general acute liver injury patterns, where elevated liver enzymes (ALT, AST) signal damage, sometimes progressing to severe cases like hepatitis or liver failure [1].
How Tigecycline Causes Liver Injury
The mechanism involves direct hepatocyte toxicity or immune-mediated reactions. Risk rises with higher doses, prolonged use (>14 days), or pre-existing liver conditions. Clinical trials reported liver-related adverse events in 1-3% of patients, with post-marketing surveillance noting rare but serious outcomes like acute liver failure [2][3].
Monitoring and Lab Signs
Doctors check liver function tests (LFTs) before and during treatment. Key indicators:
- ALT/AST >3x upper limit of normal
- Bilirubin elevation
- Alkaline phosphatase rise
Symptoms may precede lab changes; discontinue tigecycline if LFTs spike or symptoms emerge [4].
Risk Factors and Who Gets It Most
Higher incidence in:
- Elderly patients
- Those with fatty liver disease or alcohol history
- Concomitant use with other hepatotoxins (e.g., acetaminophen)
Black-box warnings highlight hepatic adverse reactions [5].
What to Do If Symptoms Appear
Seek immediate medical care. Treatment involves stopping tigecycline, supportive care (hydration, avoiding alcohol), and monitoring. Most cases resolve within weeks, but severe damage may require hospitalization [1][2].
Differences from Other Tetracyclines
Tigecycline shows higher hepatotoxicity rates (up to 10% enzyme elevations) than doxycycline or minocycline, linked to its glycylcycline structure and biliary excretion [3].
[1]: FDA Label for Tygacil (tigecycline) - https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021821s021lbl.pdf
[2]: Hepatology case reports on tigecycline hepatotoxicity - https://pubmed.ncbi.nlm.nih.gov/23913525/
[3]: LiverTox database (NIH) - Tigecycline entry - https://www.ncbi.nlm.nih.gov/books/NBK548167/
[4]: UpToDate - Drug-induced liver injury: Tigecycline - https://www.uptodate.com/contents/drug-induced-liver-injury
[5]: Pfizer Tygacil prescribing information - https://labeling.pfizer.com/ShowLabeling.aspx?id=491